Skip to main content
logo
INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.540
-0.070 (-4.35%)
At close: Oct 22, 2026, 4:00 PM EDT
1.540
0.00 (0.00%)
Pre-market: Oct 23, 2026, 4:32 AM EDT

INmune Bio Revenue

In the year 2025, INmune Bio had annual revenue of $50.00K with 257.14% growth. That makes INmune Bio the 46,522nd largest company in the world by revenue and 6,945th in the United States.

Revenue (ttm)
$50.00K
Revenue Growth
+257.14%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
21
Market Cap
42.74M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202550.00K36.00K257.14%
Dec 31, 202414.00K-141.00K-90.97%
Dec 31, 2023155.00K-219.00K-58.56%
Dec 31, 2022374.00K193.00K106.63%
Dec 31, 2021181.00K170.00K1,545.45%
Dec 31, 202011.00K--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Actinium Pharmaceuticals35.09M
Veru Inc.16.89M
Hyperion DeFi1.40M
ImageneBio800.00K
Serina Therapeutics130.00K
Revenue Rankings

INMB News

More News